Overactive Bladder Syndrome (OABS)

DBCOND0036138Nervous System DiseasesSigns, Symptoms, and General Pathologies

Overactive Bladder Syndrome (OABS) is the indication for 11 drugs in DrugBank. It is covered by 16 curated, structured indications.

Also known as
Urinary Bladder, Overactive · Overactive Bladder · Overactive Bladder Syndrome · Overactive Bladder (OAB) · Over Active Bladder
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0461241ICD-10N32.81SNOMED CT197875005MedDRA10020853UMLSC0268849

What you can answer from here — as of October 20, 2026

11Indicated drugsWith each drug's targets and mechanism
Listed above
16Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
477Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
6Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Overactive Bladder Syndrome (OABS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In